Login / Signup

Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.

Andrew J InnesLucy B CookSasha MarksEdward BataillardChristina Crossette-ThambiahGayathiri SivasubramaniamJane ApperleyDragana Milojkovic
Published in: British journal of haematology (2020)
Keyphrases
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • early onset
  • rheumatoid arthritis patients
  • drug induced
  • disease activity